Terms: = Ovarian cancer AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
7 results:
1. Assessment of tumor suppressor promoter methylation in healthy individuals.
Poduval DB; Ognedal E; Sichmanova Z; Valen E; Iversen GT; Minsaas L; Lønning PE; Knappskog S
Clin Epigenetics; 2020 Aug; 12(1):131. PubMed ID: 32859265
[TBL] [Abstract] [Full Text] [Related]
2. Increased Overall Mortality Even after Risk Reducing Surgery for
Öfverholm A; Einbeigi Z; Wigermo A; Holmberg E; Karsson P
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31888263
[TBL] [Abstract] [Full Text] [Related]
3. Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry.
Stenzel AE; Buas MF; Moysich KB
Cancer Epidemiol; 2019 Oct; 62():101580. PubMed ID: 31400533
[TBL] [Abstract] [Full Text] [Related]
4. The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
Smith HJ; McCaw TR; Londono AI; Katre AA; Meza-Perez S; Yang ES; Forero A; Buchsbaum DJ; Randall TD; Straughn JM; Norian LA; Arend RC
Cancer; 2018 Dec; 124(24):4657-4666. PubMed ID: 30423192
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth.
Turner TB; Meza-Perez S; Londoño A; Katre A; Peabody JE; Smith HJ; Forero A; Norian LA; Straughn JM; Buchsbaum DJ; Randall TD; Arend RC
Oncotarget; 2017 Jul; 8(27):44159-44170. PubMed ID: 28498806
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
Fleischmann A; Waser B; Reubi JC
Cell Oncol; 2007; 29(5):421-33. PubMed ID: 17726264
[TBL] [Abstract] [Full Text] [Related]
7. [Study of HLA molecules and its associated genes expression in human ovarian cancer cells].
Ge HL; Zhang XR; Wang Y; Ma AL; Zhang HZ; Wang SJ; Zhou GY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):41-4. PubMed ID: 15132903
[TBL] [Abstract] [Full Text] [Related]
